SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Apricus Biosciences, Inc. (APRI)

APRI RSS Feed
Add APRI Price Alert      Hide Sticky   Hide Intro
Moderator: Chillin up north
Search This Board: 
Last Post: 7/20/2017 2:26:28 PM - Followers: 190 - Board type: Free - Posts Today: 0

Apricus Biosciences, Inc. (APRI) 

 

 

http://www.apricusbio.com/

 

 

 

 

Company Address:

11975 El Camino Real, Suite 300
San Diego, CA 92130
T (858) 222-8041

 CIK:   0001017491

Apricus Website:    http://www.apricusbio.com/index.html

 

 
 

NexACT® - Multi-Route Drug Delivery Technology

NexACT® Multi-Route drug delivery technology facilitates compounds crossing the lipid bilayer and yet biodegrades in vivo to natural amino acids and natural fatty acids.

This technology is useful for:
  • Penetrating, proprietary, topical & transdermal formulations.
    Improving oral bioavailability of poorly soluble, poorly permeating compounds (BCS class 2-4)
    Delivering siRNA therapeutics into the cells; in vivo validated
    Development of more effective, penetrating cosmeceutic formulations
    Preservative

The safety and permeation properties of this proprietary drug delivery technology was demonstrated in the Vitaros® product which was approved for the treatment of erectile dysfunction in November 2010 by Health Canada, and approved by the European Union in June 2013.  Vitaros has been launched in all European Union countries by partner pharmaceutical companies.  Additional agreements for marketing Vitaros have been established.  For more information see the company's most recent 10K SEC filing.

In September 2015 the company anounced an agreement with Allergan to reacquire marketing rights for Vitaros in the U.S.  The company expects to resubmit a filing for FDA approval of Vitaros in the second half of 2016.  For more information see the company's most recent 10K SEC filing.


The company expects to initiate a Phase IIb clinical trial for RayVa to treat Reynaud's Syndrome in the second half of 2016.

In October 2014, the company acquired U.S. development and licensing rights to Fispemifene, a Selective Estrogen-Receptor Modulator (SERM) for treatment of secondary hypogonadism.  In March 2016 the company discontinued development Fispemifene after disappointing Phase IIb results.
.

 Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001017491&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share Structure:
Outstanding Shares
 61,78M

Authorized Shares
75,000,000
  

Investor Relations:
ir@apricusbio.com
Tel: +1-858 222-8041

Matthew Beck
The Trout Group
:(646)378 2933

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 


                                                                           
Image result for vitaros                                                  

Image result for vitaros

APRI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APRI News: Statement of Ownership (sc 13g) 06/16/2017 03:44:42 PM
APRI News: Statement of Changes in Beneficial Ownership (4) 06/05/2017 04:12:24 PM
APRI News: Statement of Changes in Beneficial Ownership (4) 06/05/2017 04:12:24 PM
APRI News: Statement of Changes in Beneficial Ownership (4) 06/05/2017 04:12:24 PM
APRI News: Current Report Filing (8-k) 06/05/2017 04:05:54 PM
PostSubject
#27327   absolutely correct OT. Other countries have approved and eicoman 07/20/17 02:26:27 PM
#27326   Apri holders get one benefit from Mexico if OldtimeramI 07/20/17 10:17:34 AM
#27325   many Pharmacies close to the border will carry eicoman 07/20/17 10:01:32 AM
#27324   Apri holders get one benefit from Mexico if PuuliTuku 07/20/17 03:04:31 AM
#27323   yes OT, it's been a terrible ride, the eicoman 07/19/17 02:36:18 PM
#27322   How many years did we wait for this OldtimeramI 07/19/17 02:28:05 PM
#27321   http://www.benavides.com.mx/Branch eicoman 07/19/17 10:10:37 AM
#27320   https://www.fahorro.com/storelocator/index/indexcms/ Sucursal Seleccionada: eicoman 07/19/17 10:09:05 AM
#27319   Vitaros in Mexico will be available during the eicoman 07/19/17 09:56:48 AM
#27318   Vitaros U.S. NDA Re-Submission on Track for Third mecosmo2 07/12/17 08:34:59 PM
#27317   Oldtimer I 100% agree with you ., Aprilov 07/12/17 12:42:06 PM
#27316   I quote Matt Beck " I was informed Aprilov 07/12/17 12:40:44 PM
#27315   Not saying that the Human Factors Study is OldtimeramI 07/12/17 12:35:32 PM
#27314   +1 (646) 378-2933 matt beck feel free to Aprilov 07/12/17 11:10:43 AM
#27313   Why didn't Matt Beck tell you the test casinokid11211 07/11/17 07:14:23 PM
#27312   Almost 3 million volume today, any guesses wtf PuuliTuku 07/11/17 06:42:47 PM
#27311   As per matt beck study was 100% completed Aprilov 07/11/17 10:26:01 AM
#27310   news leaking,,may xploddddeeeee $17+ myop$$$ kingsransome 07/11/17 09:44:27 AM
#27309   So there was no stiffening of penises and PuuliTuku 07/05/17 07:54:47 PM
#27308   According to Matt Beck, Human Factors Study test casinokid11211 07/01/17 08:01:17 AM
#27307   If you lift the skirt high enough you shurtha2000 06/23/17 11:39:04 AM
#27306   Very active shurtha2000 06/23/17 11:25:02 AM
#27305   On the other hand, this news is over PuuliTuku 06/21/17 01:51:46 PM
#27304   Possible effect on APRI? PuuliTuku 06/21/17 01:50:15 PM
#27303   Iroquois Capital Management, LLC has filed a new wiltonio 06/16/17 03:48:42 PM
#27302   Claytrader posted so we're definetly going under a PuuliTuku 06/09/17 03:32:06 AM
#27301   * * $APRI Video Chart 06-08-17 * * ClayTrader 06/08/17 05:12:23 PM
#27300   Rayva partner? oldcoach19 06/08/17 11:51:45 AM
#27299   In 1,09 europtiger 06/08/17 11:48:08 AM
#27298   They control it u cannot move such decision Denner carlodb1978 06/07/17 02:00:40 PM
#27297   It was pretty simple, vote NO on the casinokid11211 06/07/17 06:14:19 AM
#27296   That s right In fact they have 15 employees carlodb1978 06/07/17 01:44:09 AM
#27295   Pascoe is sitting back and laughing at all casinokid11211 06/06/17 07:11:12 PM
#27294   Management put this company in a financial position OldtimeramI 06/06/17 03:17:26 PM
#27293   Unbelievable. Wait, it's Apricus. Nothing is unbelievable here. OldtimeramI 06/06/17 01:51:47 AM
#27290   Hey Aprilov, did you get the invite to casinokid11211 05/28/17 08:02:12 AM
#27287   Vitaros will get denied by the FDA and SocialBoom 05/26/17 09:47:18 AM
#27283   Be nice everyone PJO 05/24/17 09:27:40 AM
#27281   Blowing up the offering and not allowing for Bryce Harper 05/23/17 01:31:21 AM
#27280   Institutional investors including Denner had the opportunity to casinokid11211 05/20/17 07:41:50 AM
#27279   Ditto RVL 05/18/17 12:16:46 PM
#27278   Sad to say, I am one of those mean gene 05/18/17 12:08:22 PM
#27277   Seems like you guys approved the increase in OldtimeramI 05/18/17 11:46:06 AM
#27276   Mark this post. Every proposal goes down in casinokid11211 05/17/17 06:15:35 AM
#27275   Shareholder meeting today, I have a feeling there PuuliTuku 05/17/17 05:31:32 AM
#27274   For anyone who votes yes, you deserve to casinokid11211 05/13/17 05:17:29 AM
#27273   Pascoe, how's your golf game? The club SocialBoom 05/12/17 02:57:11 PM
#27272   Havent voted. PuuliTuku 05/12/17 07:23:59 AM
#27271   Did you vote No. casinokid11211 05/12/17 06:07:34 AM
#27270   Were unused votes considered NO or was that PuuliTuku 05/12/17 05:39:02 AM
PostSubject